Acyline is a potent gonadotropin-releasing hormone (GnRH) antagonist primarily used in biomedical research. It is employed to study the role of GnRH signaling in reproductive health, particularly for its possible therapeutic applications in treating hormone-dependent cancers, such as breast and prostate cancers. Acyline's mechanism of action involves blocking the release of GnRH, leading to reduced hormone secretion.
CAT# | R1995 |
CAS | 170157-13-8 |
M.F/Formula | C80H102ClN15O14 |
M.W/Mr. | 1533.21 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Appropriate perfusion preservation solution is of great significance for reducing or slowing down various damage ...
of skin aging Natural aging of the skin results in decreased production and increased degradation of extracellu ...
Developed by the German company Hoechst Marion Roussel and derived from genetic modification of hirudin, lepirud ...
Acid-sensitive ion channels (ASICs) are a class of proton-gated ion channels belonging to the Degenerin/Epitheli ...
Ganirelix, a synthetic decapeptide compound, is a gonadotrophin-releasing hormone (GnRH) antagonist preparation ...